Georges Jourdi

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

Chrysοula Papageorgiou, Georges Jourdi, Eusebe Adjambri et al. · Clinical and Applied Thrombosis/Hemostasis · 2018 · 217 citations

Severe Sepsis, Pathology, Intravascular Coagulation +18

Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers

François‐Xavier Danlos, Claudia Grajeda‐Iglesias, Sylvère Durand et al. · Cell Death and Disease · 2021 · 161 citations · Full text

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

Aurélien Philippe, Richard Chocron, Nicolas Gendron et al. · Angiogenesis · 2021 · 124 citations · Full text

Thrombosis, Vascular Disease, Von Willebrand Factor +12

Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban

Georges Jourdi, Virginie Siguret, Anne‐Céline Martin et al. · Thrombosis and Haemostasis · 2015 · 42 citations

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants

Georges Jourdi, Maxime Delrue, Alain Stépanian et al. · Thrombosis Research · 2019 · 38 citations · Full text

Thrombosis, Venous Thrombosis, Activated Charcoal +6